Ophthalmic Anesthesia and analgesia

Effect of use of dexmedetomidine as adjuvant in single injection percutanous peribulbar anesthesia in patients presented for vitroretinal surgeries

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201603001485381

Enrollment

Registered

2016-02-23

Start date

2016-01-30

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases Surgery Anaesthesia

Interventions

Normal saline group

Dexmedetomidine group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA class I- III Aged 30- 60 years old Scheduled for vitreoretinal surgeries

Exclusion criteria

Exclusion criteria: Patients refusal Patients with glaucoma or ocular infection Patients with impaired orbital sensation Patients with suspected or known coagulopathy Patients with recent myocardial or cerebral events Patients with mental retardation

Design outcomes

Primary

Measure	Time frame
Duration of globe akinesia	—

Secondary

Measure	Time frame
Onset and duration of anesthesia	—

Countries

Egypt

Contacts

Public ContactMohamed Elshazly

Head of funding resources of magrabi eye hospital Tanta

moshhansaky@Gmail.com00201226896829

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Jun 27, 2026